The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world sequence of peptide receptor radionucleotide therapy (PRRT) and chemotherapy in patients with metastatic pancreatic neuroendocrine tumors (pNETs).
 
William James Phillips
No Relationships to Disclose
 
Elena Tsvetkova
Consulting or Advisory Role - Ipsen
Research Funding - Ipsen (Inst)
 
Macyn Leung
No Relationships to Disclose
 
Gautham Nair
No Relationships to Disclose
 
Stephen Welch
Honoraria - Eisai; GlaxoSmithKline; Merck
Consulting or Advisory Role - Amgen; Eisai
 
David Laidley
No Relationships to Disclose
 
Tim Asmis
No Relationships to Disclose
 
Michael M. Vickers
No Relationships to Disclose
 
Morgan Black
No Relationships to Disclose
 
Robin Sachdeva
No Relationships to Disclose
 
Horia Marginean
No Relationships to Disclose
 
Rachel Anne Goodwin
Honoraria - Advanced Accelerator Applications; Eisai; Incyte; Incyte; Ipsen; Merck; Pfizer
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Amgen; Apobiologix; Astellas Pharma; AstraZeneca Canada; Bayer; Eisai; Incyte; Ipsen; Merck; MSD; Novartis; Pfizer; Roche Canada; Taiho Pharmaceutical; Viatris
Speakers' Bureau - Amgen; Bayer; Bayer; Eisai; Ipsen; Merck; Mylan; Pfizer
Research Funding - Eisai; Ipsen
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer